0001415889-24-017531.txt : 20240618
0001415889-24-017531.hdr.sgml : 20240618
20240618210829
ACCESSION NUMBER: 0001415889-24-017531
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240617
FILED AS OF DATE: 20240618
DATE AS OF CHANGE: 20240618
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tsai Philip
CENTRAL INDEX KEY: 0002026600
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39580
FILM NUMBER: 241053809
MAIL ADDRESS:
STREET 1: C/O IMMUNOME, INC.
STREET 2: 18702 NORTH CREEK PARKWAY, SUITE 100
CITY: BOTHELL
STATE: WA
ZIP: 98011
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Immunome Inc.
CENTRAL INDEX KEY: 0001472012
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 770694340
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 18702 N. CREEK PARKWAY
STREET 2: SUITE 100
CITY: BOTHELL
STATE: WA
ZIP: 98011
BUSINESS PHONE: 610-321-3700
MAIL ADDRESS:
STREET 1: 18702 N. CREEK PARKWAY
STREET 2: SUITE 100
CITY: BOTHELL
STATE: WA
ZIP: 98011
4
1
form4-06192024_010626.xml
X0508
4
2024-06-17
0001472012
Immunome Inc.
IMNM
0002026600
Tsai Philip
C/O IMMUNOME, INC.
18702 N. CREEK PARKWAY, SUITE 100
BOTHELL
WA
98011
false
true
false
false
Chief Technology Officer
0
Stock option (right to buy)
13.15
2024-06-17
4
A
0
250000
0
A
2034-06-16
Common Stock
250000
250000
D
25% of the shares subject to the options vest on June 17, 2025, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.
/s/ Sandra Stoneman, Attorney-in-Fact
2024-06-18